USP28 has been validated as an oncoprotein and therapeutic target in various cancer types, and a list of oncogenic substrates of USP28 have been reported, such as JUN, NOTCH1, CCNE, and LSD1 [151,152]. The gene discussed is USP28; the disease is cancer.